HODGKIN LYMPHOMA
Clinical trials for HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer pill tested, but study halted early
Disease control TerminatedThis early-stage study tested an experimental oral drug called AUR105 in 17 adults with advanced solid tumors or lymphomas that had come back. The main goals were to check safety, how the drug moves through the body, and find the right dose. The study was stopped early, so result…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
5-Minute breathing trick may help lymphoma Survivors' hearts
Symptom relief TerminatedThis study looked at whether a simple, 5-minute daily breathing exercise using a handheld device, combined with a personalized exercise plan, could improve heart health and fitness in people who have finished treatment for lymphoma. The study aimed to recruit lymphoma survivors a…
Matched conditions: HODGKIN LYMPHOMA
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Apr 30, 2026 15:48 UTC